National Resilience, a U.S.-based biomanufacturing company, has recently announced the closure of several facilities and organizational restructuring. Given that Resilience is a major shareholder of Taiwan Bio-Manufacturing Corporation (TBMC), the news has sparked concerns about potential impacts on TBMC’s operations. On June 12, TBMC issued a formal statement clarifying that the two entities are completely independent in their operations and that TBMC's business activities remain unaffected by Resilience's restructuring.
Read more